
DEBRA is the name of an international medical research charity dedicated to securing effective drug treatments and ultimately cures for every type of epidermolysis bullosa, with national groups in over 40 countries including in the United Kingdom and the United States. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Dystrophic Epidermolysis Bullosa Research Association of America, United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
42%
Total
Publications
277
Total Open
Publications
117
Total
Citations
12K
Open Access
Percentage
42%
Total
Publications
277
Total Open
Publications
117
Total
Citations
12K
Breakdown
Publisher Open
19%
Both
18%
Other Platform Open
5%
Closed
58%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 33%
34
Hybrid 28%
28
No Guarantees 39%
40
Other Platform Open
Institution 63%
40
Domain 41%
26
Public 11%
7
Other Internet 11%
7
Preprint 2%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 26 |
doaj.org OAI-PMH Repository | Institution | 21 |
LA Referencia | Institution | 14 |
Figshare | Public | 7 |
aecid.es OAI-PMH Repository | Institution | 6 |
DOI | Other Internet | 4 |
Unknown Repository | Other Internet | 3 |
Universitat Autònoma de Barcelona | Institution | 2 |
Universidad Internacional de La Rioja | Institution | 2 |
King's College London | Institution | 2 |